ANG Lifesciences — 360° view

ANG Lifesciences, a company in the Pharmaceuticals industry, reported revenue of ₹20 crore and a net loss of ₹2.09 crore for the September 2026 quarter.

ANG Lifesciences (BSE: ANG) closed at ₹37.16 on 20 Nov 2026, up 31.9% over the past year. Its market capitalisation is ₹49 crore.

Share price
₹37.16 (20 Nov 2026)
Market cap
₹49 Cr (20 Nov 2026)
Revenue
₹20 Cr (September 2026 quarter)
Net profit
₹-2 Cr (September 2026 quarter)
ROCE
-2.32% (FY26)
ROE
-16.5% (FY26)
Book value
₹35.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹49.69 / ₹17.63 (20 Nov 2026)
1-year return
31.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: ANG

Incorporated in 2006, ANG Lifesciences India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.